BS-001

N/A

Report date: 2025/10/15 15:52:38

Base Information

Drug NameBS-001
Drug Alias NamerHSV2hGM-CSF重组人GM-CSF溶瘤II型单纯疱疹病毒（OH2）注射液（Vero细胞）Recombinant Type II Herpes Simplex Virus InjectionOncolytic type 2 Herpes Simplex virusOH-2 Oncolytic Viral Therapy +[14] 
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionColony stimulating factor 1 receptor stimulants
TargetsColony stimulating factor 1 receptor
Therapy Area/IndicationsSolid tumoursLiver DiseasesUrinary Bladder Neoplasms +[18] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesWuhan Binhui Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesWuhan Binhui Biotechnology Co LtdWuhan Binhui Biotechnology Co Ltd Biological Innovation Park Branch
Inactive CompaniesN/A
Active IndicationsSolid tumoursUrinary Bladder NeoplasmsLung Neoplasms +[14] 
Inactive IndicationsLiver DiseasesPancreatic NeoplasmsBile Duct Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A